Meeting Report
2019–2020 Drug Updates in Solid Tumors
Presented by Kirollos S. Hanna, PharmD, BCPS, BCOP
From M Health Fairview and Mayo Clinic College of Medicine, Maple Grove, Minnesota
J Adv Pract Oncol 2021;12(3):275–278 |
https://doi.org/10.6004/jadpro.2021.12.3.11 |
© 2021 Harborside™
ABSTRACT
During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hanna also discussed signs and symptoms of potential serious and life-threatening adverse events, and how new therapeutic entities will impact the advanced practice setting.
For access to the full length article, please
sign in.
